Log In
Print
BCIQ
Print
Print this Print this
 

Ondansetron lingual spray (Zensana) (BA-029)

  Manage Alerts
Collapse Summary General Information
Company Suda Ltd.
DescriptionOndansetron lingual spray
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationEmesis
Indication DetailsPrevent chemotherapy- and radiation-induced and post-operative nausea and vomiting (PONV); Prevent nausea and vomiting associated with chemotherapy and radiotherapy as well as post-operative induced nausea and vomiting; Treat chemotherapy-induced nausea and vomiting (CINV)
Regulatory Designation

Partner

Onxeo S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today